SPECIAL ARTICLE Factors associated with success of market authorisation applications for pharmaceutical drugs submitted to the European Medicines Agency

Jan Regnstrom; Franz Koenig; Bo Aronsson; Tatiana Reimer; Kristian Svendsen; Stelios Tsigkos; Bruno Flamion; Hans-georg Eichler; Spiros Vamvakas

oai:CiteSeerX.psu:10.1.1.461.4216

SPECIAL ARTICLE Factors associated with success of market authorisation applications for pharmaceutical drugs submitted to the European Medicines Agency

Authors: Jan Regnstrom
Franz Koenig
Bo Aronsson
Tatiana Reimer
Kristian Svendsen
Stelios Tsigkos
Bruno Flamion
Hans-georg Eichler
Spiros Vamvakas
Publication date: January 1, 2007
Publisher

Abstract

Purpose To identify factors associated with success of Market Authorisation Applications (MAAs) for pharma-ceutical drugs submitted to the European Medicines Agency (EMEA), with an emphasis on the Scientific Advice (SA) given by the Committee for Human Medicina

text

Similar works

Full text

CiteSeerX

Provided original full text link

oai:CiteSeerX.psu:10.1.1.461.4216Last time updated on 10/28/2017

This paper was published in CiteSeerX.

Having an issue?

Is data on this page outdated, violates copyrights or anything else? Report the problem now and we will take corresponding actions after reviewing your request.